What's Happening?
Tri Delta, a prominent sorority, has announced reaching a significant fundraising milestone by raising $25 million for St. Jude Children's Research Hospital. This achievement is part of a larger $100 million commitment aimed at supporting the hospital's
mission to treat and defeat childhood cancer and other life-threatening diseases. The announcement was made during Tri Delta's annual celebration in Memphis, attended by 400 members from over 130 chapters across the U.S. and Canada. The funds have been raised through various chapter-led initiatives, including the Delta House of Pancakes events and the Sincerely Yours letter writing campaign. Tri Delta's partnership with St. Jude, now in its 27th year, has been instrumental in ensuring that families never receive a bill for treatment, travel, housing, or food, allowing them to focus on their child's recovery.
Why It's Important?
The fundraising efforts by Tri Delta are crucial in supporting St. Jude's mission to advance research and care for children with cancer and other serious illnesses. The hospital, a National Cancer Institute-designated Comprehensive Cancer Center, has significantly improved childhood cancer survival rates from 20% to over 80% since its inception. The funds raised by Tri Delta help sustain the hospital's operations and ensure that families can access necessary treatments without financial burden. This partnership highlights the impact of community and organizational support in driving medical advancements and providing essential care to vulnerable populations.
What's Next?
Tri Delta aims to continue its fundraising efforts to meet its $100 million goal by 2038, coinciding with the 150th anniversary of the sorority's founding. The organization plans to maintain its support through ongoing initiatives and community engagement, further strengthening its partnership with St. Jude. As the hospital continues to share its research breakthroughs globally, the collaboration with Tri Delta is expected to contribute to further advancements in pediatric cancer treatment and care.
